SCNX
Scienture Holdings, Inc.
NASDAQ: SCNX · HEALTHCARE · PHARMACEUTICAL RETAILERS
$0.39
+5.08% today
Updated 2026-04-30
Market cap
$15.56M
P/E ratio
—
P/S ratio
36.05x
EPS (TTM)
$-2.70
Dividend yield
—
52W range
$0 – $3
Volume
3.6M
Scienture Holdings, Inc. (SCNX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-6225.00 | $-16068.00 | $-28.16M | $-844579.00 | $-1.06M | $-1.97M | $-1.31M | $171670.00 | $273386.00 | $141775.00 | $-2.21M | $-2.57M | $-1.56M | $-2.23M | $-14.27M | $-13.38B |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $10989.00 | $0.00 | $0.00 | $0.00 | $0.00 | $15006.00 | $82252.00 | $37505.00 | $22596.00 | $450845.00 | $2.00 | $12001.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | — | — | — | — | — | — | $1.36M | $181163.00 | $254106.00 | $257772.00 | $25584.00 | $2.07B |
| Free cash flow | $-6225.00 | $-16068.00 | $-28.16M | $-855568.00 | $-1.06M | $-1.97M | $-1.31M | $171670.00 | $258380.00 | $59523.00 | $-2.25M | $-2.59M | $-2.02M | $-2.23M | $-14.28M | $-13.38B |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | $0.00 | $14.86M | $0.00 |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |